A caller asked if GE HealthCare Technologies Inc. (NASDAQ:GEHC) is worth another look, and in response, Cramer said:
“Okay, now you know, you’re a club member, you know I sold a lot in the high 80s and then gave up on the rest. The reason I did was because it’s inconsistent and too controlled by China, not America. So I am not going to be a backer. I am going to say the fabled [don’t buy, don’t buy, don’t buy].”
A radiologist in a lab examining a computed tomography scan of a patient.
GE HealthCare develops, manufactures, and markets a range of products, services, and digital tools that support the diagnosis, treatment, and monitoring of patients. The company reported a 3% year-over-year increase in revenue for the first quarter of 2025. The adjusted EBIT margin rose to 15.0% from 14.7%, and adjusted EPS increased to $1.01 from $0.90. Furthermore, free cash flow declined to $98 million, down from $274 million in the same quarter last year.
READ NEXT: Jim Cramer Commented on These 6 Natural Gas Players and 13 Stocks on Jim Cramer’s Radar Recently
